Toft Group Completes Executive Search for Northway Biotech in San Francisco, CA

Executive search firm Toft Group has placed Ms. Tamara Smith as Vice President, Sales and Business Development at Northway Biotech in San Francisco, CA. She offers 20 years of strategic planning, complex negotiations, and extensive knowledge of bioprocessing operations in business development and sales, project management roles within the biotechnology space. She joined Northway from CMC Biologics where she held the role of Sr. Director of Business Development.

About Northway Biotech

Northway Biotech is a startup affiliate of Biotechpharma, a contract development and manufacturing organization (CDMO), supporting clients world-wide. Biotechpharma performs different projects at any stage, starting from cell line construction and process development up to cGMP production of biopharmaceutical products.

Toft Group Completes Executive Search for Ascendis Pharma Inc. (NASDAQ: ASND) in Palo Alto, CA

Executive search firm Toft Group has placed Dr. Michael Cohrs as Director of Clinical Quality at Ascendis Pharma in Palo Alto, CA. Prior to this role, he was a consultant within the biotech and pharmaceutical industries where his efforts focused on Quality Assurance, Quality Control, Quality Systems and Validation from early stage drug development through commercialization. He earned his PhD in Organic Chemistry from Washington University and an MBA from the University of Chicago.

About Ascendis Pharma Inc.

Ascendis Pharma is a clinical stage biopharmaceutical company applying its TransCon technology to develop a pipeline of long-acting prodrug therapies with best-in-class profiles to address large markets with significant unmet medical needs.

Toft Group Executive Search Named as one of the “Top 50 Healthcare & Life Sciences Search Firms” by Hunt Scanlon Media

Feb 22, 2017 – San Francisco, California: Toft Group, a global life sciences and healthcare executive recruiting firm, today announced it has been named a Top 50 Executive Search Firm in Healthcare and Life Sciences by Hunt Scanlon Media, the most widely referenced global news source in the human capital sector.

Hunt Scanlon has been ranking firms in various categories for nearly 30 years. This is the first year the news source has ranked firms in the Healthcare and Life Sciences sectors.

“Toft Group is honored to be recognized among the top executive search firms worldwide by an organization as prestigious as Hunt Scanlon,” commented Robin Toft, President & CEO of Toft Group. “Our success is attributed to our team of experienced search consultants, our commitment to delivering exceptional results and our collaborative network of partners, clients, and candidates who share the same passion for healthcare advancements and innovation.”

The complete list of search firms was published in the Healthcare and Life Sciences Recruiting Special Issue of the Hunt Scanlon Executive Search Review. Robin Toft is also highlighted as a sector expert in the feature article Life Sciences and Healthcare Search Firms Tap Outside Talent.

In the article, Toft discusses the shortage of executive talent available to effectively lead the industry through challenges and uncertainty, particularly in emerging companies that blend high-tech and biotech. This shortage is one of the reasons why companies, both inside and outside of life sciences, partner with Toft Group to fill C-level positions in a landscape where senior level executives who have leadership experience and a strong vision are critical.

“I am very proud of our search consultants’ ability to identify business leaders who create a competitive advantage and sustainable value for their companies,” added Toft.

Toft Group’s ranking as a Top 50 Executive Search Firm follows on the heels of the company being named a Top 150 Fastest Growing Private Company by the San Diego Business Journal. Toft Group has experienced double-digit revenue growth since it was established in 2010 and, to better support such growth, relocated their Northern California office to industry hotspot, the San Francisco Bay area and recently expanded its executive leadership team. These strategic decisions enhance Toft Group’s ability to support its entrepreneurial, rapidly growing client base in northern California, as well as improve access to outstanding talent for its executive search services worldwide.

About Toft Group Executive Search

Toft Group Executive Search is “Changing the Future of Medicine, One Relationship at a Time” and we take pride in the fact that our work helps our clients accelerate getting novel products to market. Named a Top 150 Fastest Growing Private Company and a Top 50 Executive Search Firm in Life Sciences, we are a global retained executive search firm that is 100% dedicated to life sciences & healthcare industries.  Our customers include biotech, pharmaceutical, medical device, digital health, and diagnostic companies. With offices in San Francisco, San Diego and Boston, we assist a wide range of local, national and international companies – from venture backed start-ups to Fortune 500 corporations. For more information, visit www.thetoftgroup.com.

About Hunt Scanlon Media

Hunt Scanlon Media has been informing the senior talent management sector for over 25 years. Our global news and intelligence data comes in many forms, including daily newswires, talent leadership reports, newsletter briefings and social media alerts. The privately-held company is headquartered in Greenwich, Conn.

Toft Group Executive Search Announces Leadership Team Expansion

Feb 15, 2017 – San Francisco, California: Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, today announced that Lucy Lu has joined the leadership team.  As Senior Vice President, Lucy will support Toft Group’s entrepreneurial, rapidly growing clients in northern California.

“We are thrilled to have Lucy Lu as the newest member of our experienced team based in San Francisco. She brings 25+ years of biotech industry experience to the role, having personally served in executive level roles for growing companies including Roche Diagnostics, Crescendo Biosciences, and Genentech,” commented Robin Toft, President & CEO of Toft Group. “Lucy is incredibly skilled at building life science executive teams, and she represents an important addition to better serve our valued customers seeking top tier talent for their growth stage companies.”

Before joining Toft Group, Lucy was the Chief Commercial Officer for iNDx Lifecare Inc., a point-of-care diagnostic startup, and SVP of Corporate and Business Development at Crescendo Bioscience Inc. She previously served as the Head of the U.S. Chief Technology Office for Roche Diagnostics, based in California and Basel, Switzerland. Additionally, Lucy held various life sciences marketing and product development positions at Roche Applied Sciences and PE Applied Biosystems (now Thermo Fisher Scientific). In her early career, she devoted 10 years to drug R&D at Genentech and Bristol-Myers Squibb.

Lucy is currently a board member of Life Science Angels (LSA). She is also the chairperson of its member education program to provide LSA members with deep angel investment knowledge to build their successful investment portfolios.

About Toft Group Executive Search

Toft Group Executive Search is “Changing the Future of Medicine, One Relationship at a Time” and we take pride in the fact that our work helps our clients accelerate getting novel products to market. Named a Top 150 Fastest Growing Private Company and a Top 50 Executive Search Firm in Life Sciences, we are a global retained executive search firm that is 100% dedicated to life sciences & healthcare industries.  Our customers include biotech, pharmaceutical, medical device, digital health, and diagnostic companies. With offices in San Francisco, San Diego and Boston, we assist a wide range of local, national and international companies – from venture backed start-ups to Fortune 500 corporations.

Toft Group Completes Executive Search for TherapeuticsMD, Inc. (NASDAQ: TXMD) in Boca Raton, FL

Executive search firm Toft Group has placed Ms. Valerie Nahay as Senior Director of Marketing at TherapeuticsMD, Inc., in Boca Raton, FL. She offers 25+ years’ experience within the healthcare industry, most recently serving with Boehringer-Ingelheim where she led their hematology marketing efforts.

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its SYMBODA™ technology, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company’s late stage clinical pipeline includes two phase 3 product candidates: TX-001HR for treatment of moderate-to-severe vasomotor symptoms (VMS) due to menopause and TX-004HR for treatment of moderate-to-severe vaginal pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA) due to menopause. The company also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaMedMD® and BocaGreenMD®brands.

Toft Group Completes Executive Search for Axovant Sciences (NYSE: AXON) in New York, NY

Executive search firm Toft Group has placed Ms. Victoria Carey as Vice President of US Marketing at Axovant Sciences in New York, NY. She brings 20+ years of global healthcare leadership to her new role. She previously served as VP, Cardiovascular Business Head at Sanofi and spent 16 years with Bristol Myers Squibb in various leadership roles. She received her MBA from the University of Pennsylvania.

About Axovant Sciences

Axovant Sciences Ltd. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to address the cognitive, functional and behavioral aspects of dementia and related neurological disorders.

Toft Group Completes Executive Search for Agendia in Irvine, CA

Executive search firm Toft Group has placed Mr. Christopher Barbazette as North American Commercial Leader at Agendia in Irvine, CA. Most recently, Mr. Barbazette served as Senior Vice President of Global Commercial Operations at Affymetrix in Santa Clara, CA. He earned a Bachelor degree in International Business – Finance from University of San Francisco, CA.

About Agendia

Agendia is a privately held, leading molecular diagnostics company that develops and markets FFPE-based genomic diagnostic products, which help support physicians with their complex treatment decisions. Agendia’s breast cancer and colorectal cancer tests were developed using an unbiased gene selection by analyzing the complete human genome. Our offerings include the FDA-cleared MammaPrint® FFPE as well as BluePrint®, a molecular subtyping assay that provides deeper insight leading to more clinically actionable breast cancer biology. These tests can help physicians assess a patient’s individual risk for metastasis – that is, which patients are more sensitive to chemo, hormonal, or combination therapy, and which patients may not require these treatments and which patients may be treated with other, less arduous and costly methods. In addition, Agendia has a pipeline of other genomic products in development. The company collaborates with pharmaceutical companies, leading cancer centers and academic groups to develop companion diagnostic tests in the area of oncology.

Toft Group Completes Executive Search for Ionetix Corporation in San Francisco, CA

Executive search firm Toft Group has placed Dr. José Zayas as Vice President of Regulatory Affairs and Quality Assurance at Ionetix Corporation in San Francisco, CA. Dr. Zayas most recently served as Director of Quality Assurance at Trelyst in Carpinteria, CA.

About Ionetix Corporation

Ionetix Corporation is engaged in the development, manufacturing and distribution of a novel class of superconductng cyclotrons for the point-of-care production of PET radioisotopes. With their significantly smaller size, lighter weight, lower power requirement and lower price point, these systems offer significant advantages over conventional-design cyclotron technology.